Continued 5 alpha-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS Article

publication date

  • January 1, 2019

webpage

published in

keywords

  • 5-alpha reductase inhibitors
  • adverse effects
  • diagnosis
  • prostatic neoplasms
  • watchful waiting

start page

  • 106

end page

  • 111

volume

  • 201

issue

  • 1